Woman and Man
- | Country :
- Belarus
- Mexico
- Belgium
- The 9 others...
- | organs : -
- | Specialty : -
Extract
This study is to assess the safety of a potential new drug DU-176b for the prevention of stroke/systemic embolic event (SEE) in individuals with non-valvular atrial fibrillation (AF). The duration is 3 months of treatment and a 30 day follow-up visit.
Inclusion criteria
- Atrial fibrillation ,Thromboembolism